RxDoctor Payments Data
★ My doctorsLook up a doctor →

Saba Mattern

Optometrist · Washington, DCNPI 1912081514

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,233 of the $10,767 with a category attached, or 67.2%. 22 manufacturers reported payments, led by Alcon at 39.9% of the total. Reporting peaked in 2019 at $4,542 and has fallen 79.4% since, to $938 in 2025. Among optometrist clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,767in general payments, 2019–2025

Across 204 payments — averaging $52.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$4K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Bausch & Lomb Americas Inc.$1K
  • Johnson & Johnson Surgical Vision, Inc.$708
  • Oyster Point Pharma, Inc.$446
  • Johnson & Johnson Vision Care, Inc.$446
  • plus $1K from 16 others

What the payments were for

  • Speaking & faculty fees$6006%
  • Travel & lodging$2,91427%
  • Food & beverage$7,23367%
  • Gifts$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alcon55$4,292
Bausch & Lomb, A Division Of Bausch Health US, LLC33$2,000
Bausch & Lomb Americas Inc.34$1,389
Johnson & Johnson Surgical Vision, Inc.6$708
Oyster Point Pharma, Inc.16$446
Johnson & Johnson Vision Care, Inc.9$446
Tarsus Pharmaceuticals, Inc.18$440
Coopervision Inc.8$210
Dompe US, Inc.3$166
ABB Con-cise Optical Group LLC6$130
Heru, Inc.1$115
Optovue, Inc.1$97
Novartis4$79
Carl Zeiss Meditec USA, Inc.1$55
Alcon Research LLC2$49
AbbVie1$29
Kala Pharmaceuticals, Inc.1$24
Sun Pharmaceutical Industries Inc.1$20
Glaukos Corporation1$20
Carl Zeiss Meditec AG1$19
Shire North American Group Inc1$16
Harrow Eye, LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,767 in reported general payments places this provider in the 95th percentile of 71 optometrist providers in District of Columbia.

See all optometrist providers in District of Columbia →

Most prescribed under Part D

DrugClaimsCost to plans & patients
XiidraLifitegrast12$8,256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bausch & Lomb Americas Inc.Xiidra$1,389$8,25612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 71 optometrist providers in District of Columbia.

Other optometrist in Washington

See the full list for District of Columbia →

Where these figures come from

Is this you, or does something look wrong? →